A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Effects of 4 Weeks Treatment with Subcutaneous Elamipretide on Left Ventricular Function in Subjects with Stable Heart Failure with Preserved Ejection Fraction: Rationale and d
29 April 2017 (08:30 - 17:30)
Organised by:
Slides
About the speaker
Scirent - Clinical Research and Science, Berlin (Germany)
8 More presentations in this session
Professor M. Boehm (Homburg, DE)
Professor J. Brugts (Rotterdam, NL)
Professor M. Kleiner Shochat (Hadera, IL)
Access the full session
The Event
Heart Failure 2017 - 4th World Congress on Acute Heart Failure
29 April 2017
08:30 CET
